Standard of care systemic therapy

DRUG2 trials

Sponsors

Dana-Farber Cancer Institute, Baptist Health South Florida

Conditions

Cutaneous T Cell LymphomaPeripheral T Cell LymphomaSpine Metastases

Phase 1

Prophylactic Radiotherapy of MInimally Symptomatic Spinal Disease

RecruitingNCT05534321

Baptist Health South FloridaSpine Metastases

Start: 2022-08-29End: 2027-09-01Target: 74Updated: 2026-02-17

Unknown Phase

A Pilot of a Microdevice For In Situ Candidate Drug Screening in Cutaneous Lesions of T-Cell Lymphoma

RecruitingNCT04045470

Dana-Farber Cancer InstituteCutaneous T Cell Lymphoma, Peripheral T Cell Lymphoma

Start: 2019-12-11End: 2027-01-01Target: 20Updated: 2024-10-08

Related Papers

Prophylactic Radiotherapy Of MInimally Symptomatic Spinal Disease (PROMISSeD): study protocol for a randomized controlled trial.

2024-01-121 citations